Victory Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

A detailed history of Victory Capital Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 99,114 shares of REGN stock, worth $104 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

99,114

Previous 92,891 6.7%

Holding current value

$104 Million

Previous $81.6 Million 16.93%

% of portfolio

0.1%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$902.69 - $993.35 $5.62 Million - $6.18 Million	6,223 Added 6.7%	99,114 $95.4 Million
Q4 2023 Feb 05, 2024	BUY	$775.18 - $881.7 $3.08 Million - $3.51 Million	3,977 Added 4.47%	92,891 $81.6 Million
Q3 2023 Nov 06, 2023	BUY	$692.45 - $844.37 $7.87 Million - $9.6 Million	11,370 Added 14.66%	88,914 $73.2 Million
Q2 2023 Jul 27, 2023	SELL	$700.03 - $830.35 $26 Million - $30.8 Million	-37,109 Reduced 32.37%	77,544 $55.7 Million
Q1 2023 May 02, 2023	BUY	$680.49 - $826.97 $16.6 Million - $20.1 Million	24,362 Added 26.98%	114,653 $94.2 Million

Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $7.61 Million - $8.26 Million	10,780 Added 13.56%	90,291 $65.1 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $8.79 Million - $9.55 Million	-12,459 Reduced 13.55%	79,511 $57.4 Million
Q3 2022 Nov 02, 2022	BUY	$573.97 - $724.32 $8.38 Million - $10.6 Million	14,603 Added 18.87%	91,970 $63.4 Million
Q2 2022 Aug 01, 2022	SELL	$548.35 - $738.84 $8.77 Million - $11.8 Million	-15,987 Reduced 17.13%	77,367 $45.7 Million
Q1 2022 May 04, 2022	BUY	$595.12 - $698.43 $1.36 Million - $1.59 Million	2,281 Added 2.5%	93,354 $61.5 Million
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $1.75 Million - $2.16 Million	3,219 Added 3.66%	91,073 $57.5 Million
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $2.17 Million - $2.57 Million	3,780 Added 4.5%	87,854 $53.2 Million
Q2 2021 Aug 03, 2021	BUY	$472.8 - $558.54 $431,666 - $509,947	913 Added 1.1%	84,074 $47 Million
Q1 2021 May 04, 2021	SELL	$446.73 - $548.2 $1.82 Million - $2.23 Million	-4,063 Reduced 4.66%	83,161 $39.3 Million
Q4 2020 Feb 01, 2021	BUY	$478.3 - $607.98 $922,640 - $1.17 Million	1,929 Added 2.26%	87,224 $42.1 Million
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $1.74 Million - $2.1 Million	3,188 Added 3.88%	85,295 $47.7 Million
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $2.86 Million - $3.73 Million	5,797 Added 7.6%	82,107 $51.2 Million
Q1 2020 May 04, 2020	SELL	$336.18 - $494.43 $2.66 Million - $3.91 Million	-7,917 Reduced 9.4%	76,310 $37.3 Million
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $2.72 Million - $3.73 Million	-9,912 Reduced 10.53%	84,227 $31.6 Million
Q4 2019 Feb 04, 2020	BUY	$274.13 - $376.51 $9.62 Million - $13.2 Million	35,098 Added 59.45%	94,139 $31.8 Million
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $14 Million - $16.3 Million	51,100 Added 643.5%	59,041 $16.4 Million
Q2 2019 Aug 15, 2019	BUY	$299.6 - $414.82 $11,384 - $15,763	38 Added 0.48%	7,941 $2.49 Million
Q1 2019 May 03, 2019	SELL	$372.08 - $439.57 $318,500 - $376,271	-856 Reduced 9.77%	7,903 $3.25 Million
Q4 2018 Feb 05, 2019	SELL	$335.82 - $403.04 $8,731 - $10,479	-26 Reduced 0.3%	8,759 $3.27 Million
Q3 2018 Nov 01, 2018	BUY	$351.14 - $408.51 $110,609 - $128,680	315 Added 3.72%	8,785 $3.55 Million
Q2 2018 Aug 02, 2018	BUY	$284.6 - $344.99 $237,641 - $288,066	835 Added 10.94%	8,470 $2.92 Million
Q1 2018 May 04, 2018	BUY	$315.82 - $393.78 $1.2 Million - $1.49 Million	3,794 Added 98.78%	7,635 $2.63 Million
Q4 2017 Feb 01, 2018	BUY	$358.63 - $469.95 $82,126 - $107,618	229 Added 6.34%	3,841 $1.44 Million
Q3 2017 Oct 27, 2017	SELL	$431.38 - $504.0 $150,983 - $176,400	-350 Reduced 8.83%	3,612 $1.62 Million
Q2 2017 Aug 07, 2017	BUY	N/A	3,962	3,962 $1.95 Million

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History